Skip to main content
Premium Trial:

Request an Annual Quote

Alex Kotzer, Mor Amitai

Premium

Compugen has appointed Alex Kotzer as president and CEO, effective Sept. Kotzer will replace Compugen's current president and CEO, Mor Amitai, who announced last October that he intends to resign from these positions before the end of the year [BioInform 11-08-04]. Kotzer most recently served as vice president at Serono and its Israeli affiliate, InterPharm.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.